Gary Charles Robb
Chief Business Officer · CORCEPT THERAPEUTICS INC
- 2024
- Sep 28, 2026
- 21
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Gary Charles Robb files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sean Maduck - $24.47M in CORT purchases and sales in the last 12 months
- Atabak Mokari - $18.73M in CORT purchases and sales in the last 12 months
- David L. Mahoney - $13.94M in CORT purchases and sales in the last 12 months
- William Guyer - $13.48M in CORT purchases and sales in the last 12 months
- Joseph K. Belanoff - $10.38M in CORT purchases and sales in the last 12 months
- Roberto Wandenkolk Vieira - $7.46M in CORT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Gary Charles Robb?
Gary Charles Robb is a corporate insider, tracked as Chief Business Officer of CORCEPT THERAPEUTICS INC (CORT). InsiderAlpha holds 21 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Gary Charles Robb submitted recently?
5 primary Form 4 filings in the last 90 days, covering 1 company.
Has Gary Charles Robb been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($2.38M) across all tracked filings.
